PTC Therapeutics Inc (PTCT)
25.26
-0.42
(-1.64%)
USD |
NASDAQ |
Apr 16, 16:00
25.26
0.00 (0.00%)
After-Hours: 17:00
PTC Therapeutics Total Assets (Quarterly): 1.896B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.896B |
| September 30, 2023 | 1.260B |
| June 30, 2023 | 1.338B |
| March 31, 2023 | 1.609B |
| December 31, 2022 | 1.706B |
| September 30, 2022 | 1.576B |
| June 30, 2022 | 1.804B |
| March 31, 2022 | 1.800B |
| December 31, 2021 | 1.938B |
| September 30, 2021 | 2.007B |
| June 30, 2021 | 2.059B |
| March 31, 2021 | 2.112B |
| December 31, 2020 | 2.208B |
| September 30, 2020 | 2.181B |
| June 30, 2020 | 1.477B |
| March 31, 2020 | 1.546B |
| December 31, 2019 | 1.624B |
| September 30, 2019 | 1.641B |
| June 30, 2019 | 1.292B |
| March 31, 2019 | 1.284B |
| December 31, 2018 | 1.119B |
| September 30, 2018 | 1.029B |
| June 30, 2018 | 511.77M |
| Date | Value |
|---|---|
| March 31, 2018 | 379.41M |
| December 31, 2017 | 391.65M |
| September 30, 2017 | 367.72M |
| June 30, 2017 | 383.08M |
| March 31, 2017 | 248.64M |
| December 31, 2016 | 269.34M |
| September 30, 2016 | 288.18M |
| June 30, 2016 | 305.56M |
| March 31, 2016 | 335.23M |
| December 31, 2015 | 365.28M |
| September 30, 2015 | 396.10M |
| June 30, 2015 | 273.82M |
| March 31, 2015 | 299.52M |
| December 31, 2014 | 333.22M |
| September 30, 2014 | 220.80M |
| June 30, 2014 | 237.56M |
| March 31, 2014 | 255.84M |
| December 31, 2013 | 151.90M |
| September 30, 2013 | 167.24M |
| June 30, 2013 | 175.47M |
| March 31, 2013 | 64.41M |
| December 31, 2012 | 13.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.260B
Minimum
Sep 2023
2.208B
Maximum
Dec 2020
1.741B
Average
1.706B
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 3.265B |
| Catalyst Pharmaceuticals Inc | 470.11M |
| Pfizer Inc | 226.50B |
| Geron Corp | 394.08M |
| Perspective Therapeutics Inc | 97.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.714B |
| Shareholders Equity (Quarterly) | -818.56M |
| Debt to Equity Ratio | -2.563 |
| Current Ratio | 2.021 |
| Net Debt Paydown Yield | -17.40% |